Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia.

Wei LiuFeiyue ZhuJiazhuo YanYi LiuCong ChenKaixuan ZhangXielan ZhaoJingyuan Chen

Published in: OncoTargets and therapy (2020)

STAT6 expression was increased in AML patients. STAT6 was found to be an adverse prognosis factor in AML patients, especially those who only received chemotherapy treatments.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
cell proliferation
acute myeloid leukemia
peritoneal dialysis
squamous cell carcinoma
emergency department
long non coding rna
clinical evaluation